| Dr Tina G Damarjian, MD | |
|
925 N 87th St, Pediatric Ophthalmology, Milwaukee, WI 53226-4812 | |
| (414) 955-2020 | |
| Not Available |
| Full Name | Dr Tina G Damarjian |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Location | 925 N 87th St, Milwaukee, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184935918 | NPI | - | NPPES |
| 1184935918 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 01071251A (Indiana) | Secondary |
| 207W00000X | Ophthalmology | 65801 (Wisconsin) | Primary |
| Entity Name | Southern California Permanente Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770515280 PECOS PAC ID: 6002729175 Enrollment ID: O20031110000678 |
News Archive
Bristol-Myers Squibb Canada and AstraZeneca Canada today announced that Health Canada has approved ONGLYZA(TM) (saxagliptin) which improves all three key measures of glycemic control - hemoglobin A1c (A1c), fasting plasma glucose (FPG) and post-prandial glucose (PPG) - when taken in combination with other commonly used oral anti-diabetic agents (metformin or a sulfonylurea).
Children with autism spectrum disorder (ASD) were more likely to have been exposed to higher levels of certain air toxics during their mothers' pregnancies and the first two years of life compared to children without the condition, according to the preliminary findings of a University of Pittsburgh Graduate School of Public Health investigation of children in southwestern Pennsylvania.
Physicians should be aware of the need to reduce the dose of sulphonylureas when adding dipeptidyl peptidase-4 inhibitor treatment in patients with Type 2 diabetes, say the authors of a meta-analysis.
New York Stem Cell Foundation (NYSCF)-Druckenmiller Fellow, Daylon James, PhD, of Weill Cornell Medial College, is lead author on a study defining conditions for generating a plentiful supply of endothelial (vessel lining) cells that are suitable for therapeutic use. Dr. James and his colleagues created a human embryonic stem cell (hESC) "reporter" line that can be used to measure endothelial cell production and activity.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tina G Damarjian, MD 925 N 87th St, Pediatric Ophthalmology, Milwaukee, WI 53226-4812 Ph: (414) 955-2020 | Dr Tina G Damarjian, MD 925 N 87th St, Pediatric Ophthalmology, Milwaukee, WI 53226-4812 Ph: (414) 955-2020 |
News Archive
Bristol-Myers Squibb Canada and AstraZeneca Canada today announced that Health Canada has approved ONGLYZA(TM) (saxagliptin) which improves all three key measures of glycemic control - hemoglobin A1c (A1c), fasting plasma glucose (FPG) and post-prandial glucose (PPG) - when taken in combination with other commonly used oral anti-diabetic agents (metformin or a sulfonylurea).
Children with autism spectrum disorder (ASD) were more likely to have been exposed to higher levels of certain air toxics during their mothers' pregnancies and the first two years of life compared to children without the condition, according to the preliminary findings of a University of Pittsburgh Graduate School of Public Health investigation of children in southwestern Pennsylvania.
Physicians should be aware of the need to reduce the dose of sulphonylureas when adding dipeptidyl peptidase-4 inhibitor treatment in patients with Type 2 diabetes, say the authors of a meta-analysis.
New York Stem Cell Foundation (NYSCF)-Druckenmiller Fellow, Daylon James, PhD, of Weill Cornell Medial College, is lead author on a study defining conditions for generating a plentiful supply of endothelial (vessel lining) cells that are suitable for therapeutic use. Dr. James and his colleagues created a human embryonic stem cell (hESC) "reporter" line that can be used to measure endothelial cell production and activity.
› Verified 8 days ago
Lincoln Shaw, Ophthalmology Medicare: Medicare Enrolled Practice Location: 2600 N Mayfair Rd Ste 901, Milwaukee, WI 53226 Phone: 773-702-3937 | |
Jay A. Met, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2600 N Mayfair Rd, #350, Milwaukee, WI 53226 Phone: 414-777-0110 | |
Jane Marie Collis-geers, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 2906 S 20th St, Milwaukee, WI 53215 Phone: 414-672-1353 Fax: 414-385-7552 | |
Jacquelyn Laplant, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 925 N 87th St, Milwaukee, WI 53226 Phone: 414-955-2020 Fax: 414-955-6300 | |
Shivam Vipul Amin, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 925 N 87th St, Milwaukee, WI 53226 Phone: 414-955-2020 Fax: 414-955-6300 | |
Meisha Raven, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2900 W Oklahoma Ave, Milwaukee, WI 53215 Phone: 414-649-3323 | |
Dr. Jane Kivlin, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 9000 West Wisconsin Avenue, Children's Hospital Of Wisconsin, Milwaukee, WI 53226 Phone: 414-805-3666 |